WELL Health Technologies - WHTCF Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: C$10.25
  • Forecasted Upside: 301.96%
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
C$2.55
▼ -0.11 (-4.14%)

This chart shows the closing price for WHTCF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New WELL Health Technologies Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for WHTCF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for WHTCF

Analyst Price Target is C$10.25
▲ +301.96% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for WELL Health Technologies in the last 3 months. The average price target is C$10.25, with a high forecast of C$12.00 and a low forecast of C$8.50. The average price target represents a 301.96% upside from the last price of C$2.55.

This chart shows the closing price for WHTCF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 1 polled investment analysts is to buy stock in WELL Health Technologies. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/24/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/22/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/22/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/21/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/19/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/17/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/17/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/16/2024

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
8/11/2023Stifel NicolausLower TargetC$13.50 ➝ C$12.00
7/19/2023TD SecuritiesBoost TargetC$7.50 ➝ C$8.50
5/10/2023ScotiabankInitiated CoverageOutperform
3/22/2023CIBCBoost TargetC$6.50 ➝ C$7.00
11/11/2022TD SecuritiesLower Target$8.00 ➝ $7.00
11/3/2022ScotiabankLower Target$7.50 ➝ $6.50
9/26/2022Maxim GroupInitiated CoverageReduce ➝ Average$9.00
(Data available from 4/16/2019 forward)

News Sentiment Rating

0.51 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/19/2023
  • 2 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/19/2023
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/18/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/18/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/17/2024
  • 2 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/16/2024
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/17/2024
  • 2 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
4/16/2024

Current Sentiment

  • 2 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
WELL Health Technologies logo
WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare. The company also develops, integrates, and sells its own suite of technology software and technology solutions to medical clinics and healthcare practitioners. In addition, it operates practitioner enablement platform, including Electronic Medical Records (EMR); telehealth platforms; practice management; AI-powered virtual assistant (WELL AI Voice); Apps.health, a digital health app marketplace; billing and revenue cycle management solutions for billing and back-office services comprising billing-as-a-service outsourcing services to doctors; and cybersecurity protection and patient data privacy solutions, as well as OSCAR Pro, an EMR platform. The company was founded in 2010 and is headquartered in Vancouver, Canada.
Read More

Today's Range

Now: C$2.55
Low: C$2.55
High: C$2.65

50 Day Range

MA: C$2.83
Low: C$2.55
High: C$3.14

52 Week Range

Now: C$2.55
Low: C$2.55
High: C$4.47

Volume

16,385 shs

Average Volume

41,453 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of WELL Health Technologies?

The following sell-side analysts have issued research reports on WELL Health Technologies in the last year: Scotiabank, Stifel Nicolaus, and TD Securities.
View the latest analyst ratings for WHTCF.

What is the current price target for WELL Health Technologies?

2 Wall Street analysts have set twelve-month price targets for WELL Health Technologies in the last year. Their average twelve-month price target is C$10.25, suggesting a possible upside of 302.0%. Stifel Nicolaus has the highest price target set, predicting WHTCF will reach C$12.00 in the next twelve months. TD Securities has the lowest price target set, forecasting a price of C$8.50 for WELL Health Technologies in the next year.
View the latest price targets for WHTCF.

What is the current consensus analyst rating for WELL Health Technologies?

WELL Health Technologies currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe WHTCF will outperform the market and that investors should add to their positions of WELL Health Technologies.
View the latest ratings for WHTCF.

What other companies compete with WELL Health Technologies?

How do I contact WELL Health Technologies' investor relations team?

WELL Health Technologies' physical mailing address is 375 Water Street, Suite 550, Vancouver, BC V6B 5C6, Canada, . The company's listed phone number is 604-628-7266. The official website for WELL Health Technologies is www.well.company. Learn More about contacing WELL Health Technologies investor relations.